Leishmaniasis refers to a group of common parasitic diseases that are highly endemic in many nations including most Middle Eastern countries. Military personnel are at risk for this vector-borne disease. Indeed, leishmaniasis reached epidemic proportions in the US military during the Operations Enduring Freedom (OEF), Iraqi Freedom (OIF) and New Dawn (OND). The ratio of asymptomatic to symptomatic leishmaniasis varies from 6:1 to 98:1 in different studies. It is therefore highly likely that there are many more unrecognized infections in our military personnel than the ~600 reported. Leishmania have the ability to persist in a host even after clinical cure. Indeed, infected humans and other hosts may never clear the infection, even after disease symptoms resolve. Leishmania are known to exert a profound effect on innate and adaptive immune responses of the host during infection. Recent evidence documents that immune effects persist even after cure of disease. Thus, it is highly likely that the immune effects of leishmaniasis extend beyond measurable symptomatic disease. Exosomes are small vesicles released from most living cells that contain protein, RNA and lipids from the cell of origin. Exosomes are now recognized as major vessels transporting immune and other response signals between host cells. Recently it was recognized that exosomes are released from Leishmania parasites. These tiny packages of information may provide clues that explain the profound systemic effects of Leishmania infection. We have already characterized the protein content of exosomes from different life stages of Leishmania infantum, one of the causative agents of leishmaniasis in the Middle East. The current proposal is based on the hypothesis that proteins and small RNAs released in exosomes from Leishmania or from Leishmania-infected cells are responsible for the dramatic and persistent local and systemic effects of leishmaniasis on immune cell responses. These effects could be invoked during active or during asymptomatic infection. Our corollary posits that Leishmania parasites themselves release exosomes whose contents affect the intracellular environment, and which become incorporated themselves into exosomes released from host cells. An understanding of the host- and parasite-derived content of released exosomes, therefore, would provide the basis for novel approaches to diagnosis and therapy of leishmaniasis.
Specific aims of this project are:
Aim #1. Identify the protein and small RNA content of exosomes, and the pathway of exosome release from macrophages infected with L. major or L. infantum. Hypothesis: Exosomes from leishmania- infected macrophages contain protein and microRNAs that promote non-classical activation of infected macrophages.
Aim #2. Identify proteins and small RNAs in the serum and urine exosomes from members of the US military who acquired cutaneous leishmaniasis in Iraq, and determine whether exosome proteins elicit an immune response in humans or in mice infected with L. major or L. infantum. Hypothesis: Exosomes released from Leishmania-infected mammalian cells contain dominant parasite antigens that generate an immune response in the infected individual.
Aim #3. Document the immunomodulatory properties of exosomes from parasites, from infected macrophages, or circulating in serum of humans with leishmaniasis. Immune responses will be tested in human macrophages and in mouse models of L. major and L. infantum infection. Hypothesis: Exosomes exhibit functional enzymatic activities that affect the activation state and the microbicidal response of both the infected and bystander host immune cells.

Public Health Relevance

Major outbreaks of the parasitic disease leishmaniasis have affected military personnel during recent operations in Iraq and Afghanistan. Most Leishmania infections are asymptomatic; thus there are likely many more infections than the ~600 reported symptomatic cases. Leishmania have dramatic effects on the host immune response and infections tend to persist long-term, leading us to hypothesize that there may be immune consequences of both symptomatic and asymptomatic infections. In this application we propose to examine the content and function of small vesicles called exosomes released from Leishmania parasites and from human cells infected with the parasite. Exosomes spread mediators of immune responses throughout the host. We hypothesize that Leishmania-derived exosomes may be responsible for the profound effects of these parasites on host immunity. These effects could be active in persons who are unaware that they are even infected.

Agency
National Institute of Health (NIH)
Institute
Veterans Affairs (VA)
Type
Non-HHS Research Projects (I01)
Project #
5I01BX000536-07
Application #
9339484
Study Section
Infectious Diseases B (INFB)
Project Start
2009-10-01
Project End
2019-06-30
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
7
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Iowa City VA Medical Center
Department
Type
DUNS #
028084333
City
Iowa City
State
IA
Country
United States
Zip Code
52246
Sousa, Rosana; Andrade, Viviane M; Bair, Thomas et al. (2018) Early Suppression of Macrophage Gene Expression by Leishmania braziliensis. Front Microbiol 9:2464
Marshall, Skye; Kelly, Patrick H; Singh, Brajesh K et al. (2018) Extracellular release of virulence factor major surface protease via exosomes in Leishmania infantum promastigotes. Parasit Vectors 11:355
Scorza, Breanna M; Wacker, Mark A; Messingham, Kelly et al. (2017) Differential Activation of Human Keratinocytes by Leishmania Species Causing Localized or Disseminated Disease. J Invest Dermatol 137:2149-2156
Rodríguez, N E; Lockard, R D; Turcotte, E A et al. (2017) Lipid bodies accumulation in Leishmania infantum-infected C57BL/6 macrophages. Parasite Immunol 39:
Christiaansen, Allison F; Dixit, Upasna Gaur; Coler, Rhea N et al. (2017) CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination. Vaccine 35:4255-4261
Weirather, Jason L; Duggal, Priya; Nascimento, Eliana L et al. (2017) Comprehensive candidate gene analysis for symptomatic or asymptomatic outcomes of Leishmania infantum infection in Brazil. Ann Hum Genet 81:41-48
Scorza, Breanna M; Carvalho, Edgar M; Wilson, Mary E (2017) Cutaneous Manifestations of Human and Murine Leishmaniasis. Int J Mol Sci 18:
Clay, Gwendolyn M; Valadares, Diogo G; Graff, Joel W et al. (2017) An Anti-Inflammatory Role for NLRP10 in Murine Cutaneous Leishmaniasis. J Immunol 199:2823-2833
Davis, Richard E; Sharma, Smriti; Conceição, Jacilara et al. (2017) Phenotypic and functional characteristics of HLA-DR+ neutrophils in Brazilians with cutaneous leishmaniasis. J Leukoc Biol 101:739-749
Davis, R E; Thalhofer, C J; Wilson, M E (2016) Infection and Activation of Human Neutrophils with Fluorescent Leishmania infantum. J Immunol Tech Infect Dis 5:

Showing the most recent 10 out of 19 publications